Fineman, M. S., Shen, L. Z., Taylor, K., Kim, D. D., & Baron, A. D. (2004). Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes. Diabetes/metabolism research and reviews, 20(5), 411-417. https://doi.org/10.1002/dmrr.499
Chicago Style (17th ed.) CitationFineman, Mark S., Larry Z. Shen, Kristin Taylor, Dennis D. Kim, and Alain D. Baron. "Effectiveness of Progressive Dose-escalation of Exenatide (exendin-4) in Reducing Dose-limiting Side Effects in Subjects with Type 2 Diabetes." Diabetes/metabolism Research and Reviews 20, no. 5 (2004): 411-417. https://doi.org/10.1002/dmrr.499.
MLA (9th ed.) CitationFineman, Mark S., et al. "Effectiveness of Progressive Dose-escalation of Exenatide (exendin-4) in Reducing Dose-limiting Side Effects in Subjects with Type 2 Diabetes." Diabetes/metabolism Research and Reviews, vol. 20, no. 5, 2004, pp. 411-417, https://doi.org/10.1002/dmrr.499.